Standard BioTools Inc

Standard BioTools Inc. has a portfolio of technologies that help biomedical researchers develop medicines faster. The Company develops, manufactures, and sells a diversified range of instrumentation, consumables, and services. The Company offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research. Its proprietary multi-omics tools provide unique insights into human health, immune response, and disease states across a broad range of applications, including proteomics and genomics, and other areas of translational and clinical research. The Company's solutions are designed to unlock complex biological information across plasma, single-cell, and spatial proteomics, as well as genomic analyses, enabling researchers to explore disease mechanisms with unprecedented depth and precision. Its advanced platforms are CyTOF and Hyperion.